BeiGene
BeiGene (Beijing) Co., Ltd. is a life sciences biotechnology company
2164 employees · est. 2010 · Cambridge, United States
Incyte
Pharmaceutical Research | Oncology Product Development | Incyte.com
3425 employees · est. 1991 · Wilmington, United States
Incyte is the older company (2010 vs 1991).
Side-by-Side Comparison
| Metric | BeiGene | Incyte |
|---|---|---|
| Founded | ||
| Founded | 2010 | 1991 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | Wilmington, United States |
| Employees | ||
| Employees | 2164 | 3425 |
| Industry | ||
| Industry | Not tracked yet | Not tracked yet |
| Funding Stage | ||
| Funding Stage | IPO | IPO |
| Total Funding | ||
| Total Funding | $6.69B | $44.30M |
| Funding Rounds | ||
| Funding Rounds | 9 | 2 |
| Services | ||
| Services | Cancer Treatment Development, Clinical Research and Trials, Patient Assistance Programs, Biopharmaceutical Manufacturing | Development of innovative medicines, Research and development in Hematology and Oncology, Treatment for Inflammation and Autoimmunity, Clinical program management, Partnership development |
| Target Customers | ||
| Target Customers | Cancer Patients, Healthcare Providers, Medical Researchers, Investors | Patients, Healthcare professionals, Medical institutions |
| Taxonomy | ||
| Taxonomy | Life Sciences, Innovative Medicines, Cancer Treatment, Immuno-oncology, Hematology, Oncology, Targeted Therapy, Global Rebranding, Patient Partnerships, Pharmaceutical Development, Therapeutic Innovation, Global Healthcare, Redomiciliation, Shareholder Engagement | Pharmaceutical Research, Oncology Product Development, Biopharmaceutical Company, Innovative Medicines, Clinical Candidates, Medicinal Chemistry, Inflammation & Autoimmunity, Dermatology, First-in-Class Medicines, Oncology, Targeted Therapy, Immuno-oncology, Immunology, Healthcare Advances, Pipeline Development |
| Website | ||
| Website | beonemedicines.com | incyte.com |
About BeiGene
BeiGene, now rebranding as BeOne Medicines Ltd., is a notable player in the life sciences biotechnology sector. Founded in 2010, the company has been instrumental in developing innovative cancer therapies. The company recently changed the name of its U.S. subsidiary to BeOne Medicines USA, Inc. as...
About Incyte
Incyte, founded in 1991, is a global leader in the biopharmaceutical landscape, known for its commitment to resolving unmet medical needs through innovative drug discovery and development in the fields of oncology and inflammation & autoimmunity. With its headquarters in Wilmington, Delaware, the co...
We will tell you when either one moves
BounceWatch watches BeiGene and Incyte for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at BeiGene and Incyte — by email.
Frequently Asked Questions
Compare BeiGene with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at BeiGene on 11 Mar 2026, and Incyte on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.